Clinical trials
Altitude Sickness trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 2 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 9 |
| Recruiting | 5 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affiliated Hospital of Qinghai University | 3 |
| Macao Polytechnic University | 3 |
| Children's Hospital of Fudan University | 2 |
| Peking University People's Hospital | 2 |
| State Key Laboratory of Respiratory Disease | 2 |
| Tasly Pharmaceuticals, Inc. | 2 |
| Third Military Medical University | 2 |
| Beijing Chao Yang Hospital | 1 |
| Capital Medical University | 1 |
| Ji Xunming,MD,PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Altitude Sickness | 29 |
| Hypoxia | 6 |
| Breast Neoplasms | 2 |
| Mucopolysaccharidosis IV | 2 |
| Respiratory Aspiration | 2 |
| Cardiotoxicity | 1 |
| Cognitive Dysfunction | 1 |
| Esophagitis, Peptic | 1 |
| Fatigue | 1 |
| Gastritis, Atrophic | 1 |
Trials
Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.